Syrian healthtech Moadna raises $50,000 in early funding

Published: 2026-06-18T09:43:55.000Z

In a region where funding headlines are usually measured in millions, a $50,000 cheque might look like a rounding error. But in Syria, a country only beginning to rebuild, it is a genuine milestone. Moadna, a Syrian healthtech startup for clinic management and appointment booking, has raised $50,000 in early stage funding.

In a region where funding headlines are usually measured in millions, a $50,000 cheque might look like a rounding error. But in Syria, a country only beginning to rebuild after years of conflict and isolation, it is a genuine milestone. Moadna, a Syrian healthtech startup that runs a digital platform for clinic management and appointment booking, has raised $50,000 in early stage funding from angel investors, a round that values the young company at around $300,000. The amount matters far less than the signal, which is that private capital is starting to flow toward homegrown Syrian technology companies at all. The product is the kind of unglamorous but practical software that healthcare systems everywhere quietly depend on. Founded by Tarek Skheta and Maged Hamdeh, Moadna gives clinics and medical centres an integrated way to manage their operations and lets patients book appointments digitally, replacing the phone calls and paper diaries that still dominate much of the sector. The traction it has built in a difficult market is what made it fundable, with the platform now serving more than 550 doctors, clinics and medical centres, a user base of over 8,000 people, and more than 3,500 appointments booked to date. Those are modest numbers globally, but meaningful in a country where digital infrastructure has been battered and trust in new platforms has to be earned slowly. The plan for the money is sensible rather than flashy. Moadna intends to use the funding to improve its product, strengthen its technology infrastructure, and expand its commercial operations, all as groundwork ahead of a planned pre seed round. In other words, this is an early bridge meant to sharpen the company before it goes after a larger, more formal raise, the typical ladder a startup climbs as it matures. The company has also come up through Thimar, a support programme dedicated specifically to Syrian startups, which points to the slow emergence of an ecosystem designed to nurture local founders rather than leave them to fend for themselves. What gives the story weight is the context surrounding it. Syria's startup scene has been almost entirely cut off from the regional venture flows that have transformed the Gulf, Egypt and the Levant, hobbled by conflict, sanctions and a collapsed economy. A round this size, backed by angel investors willing to value a Syrian healthtech company at $300,000, is a small but real sign that capital is beginning to test the waters as the country looks toward reconstruction. Healthcare is also a logical place to start, since rebuilding medical access is among the most urgent national priorities. The regional read is one of cautious widening. Across the Middle East and North Africa, healthtech has been a steadily growing magnet for investment, with the UAE, Saudi Arabia, Egypt and Jordan producing platforms like Okadoc, Altibbi and Vezeeta that have raised tens of millions. Syria sits far behind that frontier, but Moadna's raise hints that the same playbook, digital clinic management, appointment booking and eventual regional expansion, could eventually take root there too, one small cheque at a time.